🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Healthcare Sector SEC Filings — August 21, 2026

The two S&P 500 Healthcare filings today reveal a pattern of insider selling, albeit at low materiality levels, suggesting routine portfolio management rather than acute bearish sentiment. Gilead Sciences shows a director executing a 10b5-1 plan with a net sale of ~$167K after exercising options, indicating pre-planned diversification. Intuitive Surgical's EVP sold a minimal ~$30.5K worth of stock, also under a 10b5-1 plan, reflecting standard compliance selling. No period-over-period trends, forward guidance, capital allocation changes, or M&A activity were present in these filings, limiting the depth of cross-company synthesis. The sector theme is muted insider activity with no red flags, but the lack of bullish signals (e.g., insider buying, guidance raises) keeps the overall tone neutral. Investors should monitor upcoming earnings calls and any shifts in insider behavior for clearer directional cues.

2 high priority 2 total filings
· daily

US Earnings Financial Results SEC Filings — August 21, 2026

The 13 filings reveal a bifurcated market: established industrial and tech companies (OSI Systems, Sysco, Ubiquiti, Parker-Hannifin) show moderate revenue growth (3-27% YoY) but face margin compression and rising costs, while a cluster of micro-cap and SPAC entities (Game Your Game, Bubblr, GridAI, Freedom Metals, FG Merger II) are in severe financial distress with collapsing revenues, widening deficits, and cash depletion. The banking sector (Kearny Financial) shows strong earnings growth (+39% YoY) but rising non-performing assets signal credit risk. Key themes include: 1) margin pressure from restructuring and impairment charges (OSI, GridAI), 2) a wave of cash-burning pre-revenue companies with negative sentiment, and 3) capital allocation diverging between buybacks/dividends (Ubiquiti, OSI) and debt-fueled survival (La Rosa). Insider trading data was sparse, but forward-looking statements from OSI and Parker-Hannifin suggest cautious optimism on organic growth. The most actionable signals are Ubiquiti's margin expansion and Kearny's earnings beat, while the highest risks are concentrated in the micro-cap cohort where cash runs are measured in months.

13 high priority 13 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 21, 2026

This batch of 12 proxy filings reveals a concentrated theme of capital structure engineering and shareholder dilution, particularly among small-cap and micro-cap companies. Theravance Biopharma's merger vote, Classover Holdings' massive authorized share increase, and VivoSim Labs' reverse split and warrant repricing are the most material events, each carrying significant implications for existing equity holders. While Neogen Corp stands out with a clear operational turnaround story—core revenue growth, deleveraging, and a planned 50% R&D increase—most other filings lack detailed financial performance data, limiting period-over-period comparisons. Insider trading activity is notably absent across all filings, which is a neutral signal but removes a key conviction indicator. The overarching theme is one of corporate action (mergers, dilutive financings, equity plan amendments) rather than operational performance, creating a high-risk, high-potential-reward environment for active investors. The forward-looking catalyst calendar is packed with special and annual meetings in September and October 2026, providing clear near-term event-driven opportunities.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 21, 2026

The IPO pipeline is active with 8 filings on August 21, 2026, spanning biotech, gaming, energy, and semiconductor sectors. The dominant theme is capital-intensive, pre-revenue or early-stage companies seeking public funding, with 5 of 8 filings being S-1 registrations for IPOs or follow-on offerings. A critical pattern is the prevalence of 'going concern' risks and heavy reliance on dilutive financing, particularly in the biotech space (Aptevo, Tempest, Alzamend). The largest transaction is ON Semiconductor's acquisition of Synaptics, a $4B+ deal that has seen the acquirer's stock price decline 30% since announcement, creating valuation uncertainty. Insider trading data is sparse, but capital allocation trends show a clear preference for equity financing over debt, with several companies using deep-discount convertible instruments (Alzamend) or at-the-market facilities (Tempest). The pipeline is characterized by high risk, high dilution, and speculative valuations, with few mature, profitable companies seeking public listing.

8 high priority 8 total filings
· daily

US Executive Officer Management Changes SEC — August 21, 2026

This digest covers 30 filings, with 21 new and 9 context items, focused on US executive and director changes. The most critical development is a leadership vacuum at **New Fortress Energy** (CFO resigned with no interim named) and a sudden COO termination at **Nerdy** without explanation, signaling potential operational distress. Conversely, **BJ's Wholesale Club** delivered standout operational results (sales +15.9% YoY, EPS +19.3%) and raised guidance, contrasting with mixed signals from **James River Group** (underwriting loss despite profit growth). A notable pattern is the strategic positioning of CFO appointments: **Vertical Data** hired a CPA to lead an uplisting, while **Synaptics** lost its CFO to a competitor amid a pending merger, creating execution risk. The overall tone is cautious, with 7 filings showing negative or mixed sentiment, but pockets of strength exist in consumer staples and niche financial services. Insider activity is sparse, but the capital allocation trend (dividend at United Fire Group, equity grants at Home Depot and Northrop Grumman) suggests a focus on retention and shareholder returns.

30 high priority 30 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 21, 2026

The 30 filings reveal a dynamic period of board and executive leadership changes across US-listed companies, with a notable concentration of CFO transitions and strategic realignments. Key themes include a wave of CFO appointments and departures, often tied to M&A activity or strategic pivots (e.g., Synaptics, Qnity Electronics, Vertical Data), and several board departures unrelated to company disagreements. While most changes are routine, several carry material implications: NEXGEL's leadership transition and strategic review, New Fortress Energy's sudden CFO resignation without an interim named, and Nerdy's unexplained COO termination signal elevated execution risk. On the positive side, BJ's Wholesale Club reported strong Q2 results with 15.9% revenue growth and raised guidance, while James River Group showed improved net income despite underwriting challenges. The period-over-period data from the two earnings filings shows a mixed picture: BJ's demonstrated robust top-line growth and margin discipline, while James River's group combined ratio of 100.2% indicates overall underwriting pressure. Insider trading activity was absent from these filings, but capital allocation signals were present through United Fire Group's continued dividend and Northrop Grumman's performance-based CEO retention grant. The overall sentiment across filings is predominantly neutral, with pockets of positive (BJ's, Qnity, United Fire) and negative (New Fortress Energy, Nerdy) signals.

30 high priority 30 total filings
· daily

USA Corporate Actions — August 21, 2026

The sole filing analyzed for August 21, 2026, is from Gabelli Dividend & Income Trust, which filed an 8-K amending the terms of its Series M Cumulative Preferred Shares. The key changes include extending the mandatory redemption date by two years to December 26, 2028, and introducing new holder put dates in 2027 and 2028, alongside a mandatory put mechanism in December 2026 with an opt-out provision. The authorized share count for the series was also increased from 30 million to 50 million. This corporate action is neutral in sentiment and moderate in materiality, reflecting a strategic restructuring of preferred share terms rather than a fundamental shift in the company's financial health. No period-over-period comparisons, insider trading activity, or forward-looking guidance were provided in the filing, limiting the depth of trend analysis. The primary takeaway is that the trust is proactively managing its capital structure to provide flexibility and optionality for preferred shareholders, which may appeal to income-focused investors.

1 medium 1 total filings
· daily

USA Insider Trading Pulse — August 21, 2026

The August 21, 2026 insider trading pulse reveals a pronounced bearish tilt, with 18 sell transactions versus 7 buy transactions, though many sells are executed under Rule 10b5-1 plans, reducing their alarmist signal. The most significant insider activity clusters in the technology and growth sectors, where multiple C-suite executives at Sea Ltd, Freshpet, and Twist Bioscience are monetizing equity awards, often at substantial gains. A notable insider buying theme emerges in the financial services and small-cap value space, with directors and CEOs at Lument Finance Trust, Alico, and NB Bancorp adding to their positions, signaling confidence in undervalued assets. The data also shows a wave of equity grants and awards at Parker-Hannifin and Calumet, indicating a focus on long-term incentive alignment. Overall, the digest suggests a market where growth insiders are taking profits while value-oriented insiders are deploying capital, pointing to a potential rotation away from high-multiple growth stocks toward more defensive, asset-backed names.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 21, 2026

The August 21, 2026 M&A and takeover landscape is dominated by SPAC activity, with 5 of 8 filings involving blank-check companies, signaling a continued but cautious market for de-SPAC transactions. A notable trend is the prevalence of regulatory and compliance challenges, as two SPACs (K&F Growth Acquisition Corp. II and Breeze Acquisition Corp. II) received Nasdaq deficiency notices for listing rule violations, highlighting heightened scrutiny on SPAC governance and reporting. The only operational company with a material transaction, Elutia Inc., executed a strategic divestiture of its SimpliDerm business for up to $11 million, generating non-dilutive capital to fund its high-potential NXT-41x product, though it now faces increased product concentration risk. Liberty Broadband Corp's filing signals a significant upcoming merger through the creation of a merger subsidiary, while RocketFuel Blockchain completed an undisclosed acquisition, creating uncertainty. The Bleichroeder Acquisition Corp. II filing provides specific deal economics for its Pasqal business combination, including a $1.85 million closing fee, offering a rare glimpse into SPAC sponsor incentives. Overall, the digest reveals a market where SPACs are navigating operational and regulatory hurdles, while select operating companies are reshaping their portfolios through targeted M&A.

8 high priority 8 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 20, 2026

The six insider sales filings from S&P 500 Technology leaders dominate intelligence, revealing broad-based executive profit-taking at sector highs. Despite a stellar earnings quarter from Applied Materials (net income up 44.5% YoY, EPS up 46.6%), a sharp capital allocation shift from buybacks to reinvestment suggests management sees higher growth returns from capex (+34.8% YoY), creating a nuanced outlook. A notable cluster of C-suite and board sales across AMD ($3M+ in CEO sales), Micron ($14M single insider sale), CrowdStrike ($806K CEO sale), Cisco, and Apple within 48 hours signals a potential sector peak. The stark divergence between AMD's weak insider sentiment (no insider purchases, only pre-planned sales) and its operational momentum remains the key market puzzle, while Micron's massive insider liquidation at $934 stock price flags extreme valuation risk.

7 high priority 1 medium 8 total filings
· daily

New Federal Contractors — August 20, 2026

The five contracts analyzed total $1.84 billion in obligations, all from civilian agencies with no defense-related awards, signaling a strong civilian procurement environment. The dominant theme is health and IT services, led by Emergent Product Development Gaithersburg Inc.'s massive $1.41 billion HHS contract, which alone accounts for 77% of total value and is the highest-conviction bullish signal. Other notable awards include Guidehouse Inc.'s $124.5 million DOJ ICAM contract and Managed Care Advisors Inc.'s $106.9 million CDC provider network deal, both reflecting stable civilian demand. However, the lack of defense contracts and the presence of three neutral signals (Yulista Tactical Services LLC, Managed Care Advisors Inc., Cherokee Strategic Solutions LLC) highlight execution and budget risks, particularly for fixed-price contracts like Cherokee's $81.8 million FAA weather systems award. Key watch items include option exercises for Guidehouse and Cherokee, and potential follow-on contracts for Emergent.

5 total filings
· daily

Significant Contract Modifications ($10M+) — August 20, 2026

This digest covers $1.84B in civilian agency contract obligations from August 20, 2026, with zero defense-related awards, underscoring a sharp divergence from DOD spending patterns. The dominant theme is a massive, sole-source-like $1.41B award to Emergent Product Development Gaithersburg Inc. from HHS, which accounts for 77% of total value and is the highest-conviction signal, though its lack of competitive detail introduces opacity. A competitive $124.5M ICAM win for Guidehouse Inc. at DOJ provides the clearest bullish signal for federal IT services. Key risks include the expired performance period for Yulista Tactical Services LLC’s $115M NASA contract and the early-stage execution risk on Cherokee Strategic Solutions’ $81.8M fixed-price FAA weather systems contract. Investors should watch for HHS budget justification for the Emergent award and DOJ option exercises on Guidehouse's contract.

5 total filings
· daily

Contract Deobligations Alert — August 20, 2026

This digest covers five contracts totaling $1.84 billion, all from civilian agencies (0% defense-related), with the Department of Health and Human Services dominating via a single $1.41 billion award to Emergent Product Development Gaithersburg Inc. The highest-conviction signal is Guidehouse Inc.’s $124.5 million ICAM contract with the Department of Justice, reflecting a competitive win in a high-priority federal cybersecurity area. Key risk centers on the massive Emergent contract: its age (2016), unknown pricing structure, and lack of recent performance data create opacity around revenue realization and potential deobligation exposure. Overall, the digest points to civilian IT and health services spending stability, but with limited near-term growth catalysts outside of Guidehouse’s potential option exercises.

5 total filings
· daily

Contract Option Exercises — August 20, 2026

This digest covers five civilian agency contract option exercises totaling $1.84 billion, with zero defense-related awards, underscoring a pronounced shift toward non-DOD spending in this period. The dominant signal is a massive $1.41 billion sole-source award to Emergent Product Development Gaithersburg Inc. from HHS, representing 77% of total obligation and signaling deep competitive moats in biodefense or medical countermeasures. Guidehouse Inc.'s $124.5 million DOJ cybersecurity win reinforces civilian IT security as a durable growth theme. Key risks include execution pressure on Cherokee Strategic Solutions' $81.8 million fixed-price FAA contract and the expired performance period for Yulista Tactical Services' NASA award, which limits forward visibility.

5 total filings
· daily

Federal Professional Services Contracts — August 20, 2026

This digest covers a single civilian federal professional services contract totaling $81.8 million in obligations, with no defense-related awards. The sole award to Cherokee Strategic Solutions, L.L.C. under the FAA's weather systems tech refresh program highlights a niche but stable demand for specialized engineering services from socioeconomically designated firms. The contract's firm-fixed-price structure and early-stage execution (only $846K outlayed) introduce material performance risk despite multi-year revenue visibility. The highest-conviction signal is neutral, reflecting the balance between a strong 8(a) competitive moat and the execution challenges inherent in fixed-price, long-duration tech refresh work. Key risk is the high pricing risk under the fixed-price structure, which could compress margins if cost overruns occur.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — August 20, 2026

This digest covers a single but highly material civilian contract: a $124.5 million time-and-materials BPA call awarded to Guidehouse Inc. by the Department of Justice for ICAM (Identity, Credential, and Access Management) services. The contract has a total potential value of $273.8 million if all options are exercised, representing a significant revenue stream for Guidehouse through 2029. The award was made under full and open competition, signaling a competitive win on technical merit, and aligns with the high-priority federal cybersecurity theme. However, the time-and-materials pricing structure introduces medium execution risk, and the contract's stability depends on DOJ's exercise of option years.

1 total filings
· daily

All HHS Contracts — August 20, 2026

This digest covers two HHS contracts totaling $1.52B, with zero defense exposure, highlighting a dominant civilian agency theme. The standout signal is Emergent Product Development Gaithersburg Inc.'s $1.41B sole-source-like award from HHS, representing 93% of total value, which is a massive bullish signal for the company but carries concentration risk given its unknown competitive moat and pricing structure. The second contract, Managed Care Advisors Inc.'s $107M CDC provider network deal, is neutral, offering stable multi-year revenue through November 2026 but with moderate competitive pressure from full-and-open competition. Key risk: Emergent's contract lacks transparency on pricing and competition, making it vulnerable to protests or budget scrutiny, while the CDC contract's time-and-materials pricing limits margin upside.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — August 20, 2026

This digest covers $1.76 billion in contracts for August 20, 2026, all from civilian agencies (0/4 defense-related), with an average signal strength of 6.3/10. The standout award—$1.41 billion to Emergent Product Development Gaithersburg Inc. from HHS—dominates the aggregate and is a high-conviction bullish signal, though its defense classification is anomalous. Guidehouse Inc. ($124.5M from DOJ) and Managed Care Advisors Inc. ($106.9M from CDC) offer moderate revenue visibility in federal IT and health services, respectively. Key risk: the $1.41B Emergent contract has no pricing or competition details, creating execution uncertainty; its 2016 award date also raises obsolescence questions for current portfolio decisions.

4 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 20, 2026

The August 20, 2026, filing batch for the NASDAQ-100 stream is dominated by a cluster of insider selling by senior executives across major tech names, including Meta, AMD, Apple, Cisco, Micron, and CoreWeave, generating a cautious tone for the sector. While these sales are largely executed under 10b5-1 plans, suggesting pre-planned diversification, the aggregate value and concentration of high-level exits within a single day create a near-term sentiment headwind. The lone material operating update from Applied Materials (AMAT) provides a significant positive counterweight, reporting a 44.5% YoY jump in net income and strong 46.6% EPS growth, confirming robust demand in the semiconductor equipment space. This divergence between exceptional operational performance at AMAT and the widespread insider profit-taking across the sector defines the current mixed picture. The most critical development is the CEO of CoreWeave, a high-growth AI company, monetizing $6.85 million in stock, which, given the company's nature, is a notable datapoint for the AI infrastructure theme.

10 high priority 1 medium 11 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 20, 2026

This digest of 48 activist and institutional filings reveals a market characterized by significant insider conviction in micro-cap turnaround situations, particularly in the biotechnology and specialty finance sectors, alongside notable institutional accumulation in large-cap value names like Republic Services. A key theme is the emergence of activist-like engagement from previously passive investors, such as Conifer Management's switch to a 13D for Group 1 Automotive, signaling a more active stance. Insider buying at Hepion Pharmaceuticals and the strategic accumulation by Christian Angermayer's group in Enhanced Group Inc. point to high-conviction bets on distressed assets. Conversely, the digest highlights a wave of insider selling and exit filings, including the dissolution of the Brera Holdings group and the reduction of stakes in Cimpress and Tredegar, suggesting a rotation out of certain positions. The data also reveals a cluster of passive institutional stakes in small-cap and micro-cap companies, indicating a search for alpha in less efficient markets. Overall, the period-over-period comparisons and insider activity patterns suggest a bifurcated market where insiders are aggressively backing their own turnarounds while reducing exposure to others, creating both high-risk and high-opportunity scenarios.

20 high priority 28 medium 48 total filings